Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Response Pharmacogenetic Study of ADHD

NCT00663442 is registered in ClinicalTrials.gov with University of Illinois at Chicago as lead sponsor.

NCT NCT00663442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00663442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Response Pharmacogenetic Study of ADHD
Lead sponsor
University of Illinois at Chicago
Phase
Phase 4
Overall status
Completed
Start date
December 31, 1999
Completion date
November 30, 2004
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adhd